U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Reduced hepatic N-acetylglutamate synthase activity

MedGen UID:
1054381
Concept ID:
CN376674
Finding
HPO: HP:6000161

Definition

Concentration or activity of N-acetylglutamate synthase in liver tissue below the lower limit of normal. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVReduced hepatic N-acetylglutamate synthase activity

Conditions with this feature

Hyperammonemia, type III
MedGen UID:
120649
Concept ID:
C0268543
Disease or Syndrome
N-acetylglutamate synthase deficiency (NAGSD) is an autosomal recessive disorder of the urea cycle. The clinical and biochemical features of the disorder are indistinguishable from carbamoyl phosphate synthase I deficiency (237300), since the CPS1 enzyme (608307) has an absolute requirement for NAGS (Caldovic et al., 2007).

Recent clinical studies

Etiology

Yabuki M, Kon-Ya Y, Kataoka M, Shimizudani T, Akao K, Ito M, Kanamaru H, Nakatsuka I
Eur J Drug Metab Pharmacokinet 2003 Jan-Mar;28(1):21-9. doi: 10.1007/BF03190863. PMID: 14503661

Diagnosis

Chen Z, Eggerman TL, Bocharov AV, Baranova IN, Vishnyakova TG, Csako G, Patterson AP
RNA 2010 May;16(5):1040-52. Epub 2010 Mar 26 doi: 10.1261/rna.1863010. PMID: 20348446Free PMC Article

Clinical prediction guides

Aires CC, van Cruchten A, Ijlst L, de Almeida IT, Duran M, Wanders RJ, Silva MF
J Hepatol 2011 Aug;55(2):426-34. Epub 2010 Dec 13 doi: 10.1016/j.jhep.2010.11.031. PMID: 21147182

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...